Nothing Special   »   [go: up one dir, main page]

ATE235922T1 - Verfahren zum nachweis oder zur überwachung der wirksamkeit der behandlung durch t-zellen vermittelter erkrankungen - Google Patents

Verfahren zum nachweis oder zur überwachung der wirksamkeit der behandlung durch t-zellen vermittelter erkrankungen

Info

Publication number
ATE235922T1
ATE235922T1 AT96923689T AT96923689T ATE235922T1 AT E235922 T1 ATE235922 T1 AT E235922T1 AT 96923689 T AT96923689 T AT 96923689T AT 96923689 T AT96923689 T AT 96923689T AT E235922 T1 ATE235922 T1 AT E235922T1
Authority
AT
Austria
Prior art keywords
treatment
effectiveness
monitoring
detecting
cell mediated
Prior art date
Application number
AT96923689T
Other languages
English (en)
Inventor
Irun R Cohen
Dana Elias
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE235922T1 publication Critical patent/ATE235922T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Physiology (AREA)
  • Ecology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
AT96923689T 1995-07-05 1996-07-02 Verfahren zum nachweis oder zur überwachung der wirksamkeit der behandlung durch t-zellen vermittelter erkrankungen ATE235922T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11445995A IL114459A0 (en) 1995-07-05 1995-07-05 Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases
PCT/US1996/011374 WO1997002052A1 (en) 1995-07-05 1996-07-02 Method for detecting or monitoring the effectiveness of treatment of t cell mediated diseases

Publications (1)

Publication Number Publication Date
ATE235922T1 true ATE235922T1 (de) 2003-04-15

Family

ID=11067728

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96923689T ATE235922T1 (de) 1995-07-05 1996-07-02 Verfahren zum nachweis oder zur überwachung der wirksamkeit der behandlung durch t-zellen vermittelter erkrankungen

Country Status (7)

Country Link
EP (1) EP0847281B1 (de)
JP (1) JP3905126B2 (de)
AT (1) ATE235922T1 (de)
AU (1) AU6454396A (de)
DE (1) DE69627161T2 (de)
IL (1) IL114459A0 (de)
WO (1) WO1997002052A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022697A (en) * 1996-11-29 2000-02-08 The Regents Of The University Of California Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus
AU2003209623A1 (en) * 2002-02-19 2003-09-09 Yeda Research And Development Co. Ltd. Dual-effect ligands comprising anti-inflammatory hsp peptide epitopes for immunomodulation
US8691772B2 (en) * 2005-01-04 2014-04-08 Yeda Research And Development Co. Ltd. HSP60, HSP60 peptides and T cell vaccines for immunomodulation
US20070031482A1 (en) * 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
JP4283812B2 (ja) * 2006-01-06 2009-06-24 財団法人工業技術研究院 重症筋無力症の診断方法およびそのキット

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006630A1 (en) * 1994-08-26 1996-03-07 The Regents Of The University Of California Methods and compositions for modulating a t cell response

Also Published As

Publication number Publication date
IL114459A0 (en) 1995-11-27
EP0847281A1 (de) 1998-06-17
DE69627161D1 (de) 2003-05-08
DE69627161T2 (de) 2004-02-19
JP2001520740A (ja) 2001-10-30
EP0847281B1 (de) 2003-04-02
WO1997002052A1 (en) 1997-01-23
AU6454396A (en) 1997-02-05
JP3905126B2 (ja) 2007-04-18
EP0847281A4 (de) 2002-01-30

Similar Documents

Publication Publication Date Title
DE69940470D1 (de) Vorrichtung und verfahren für die thermometrie
ATE442592T1 (de) Detektion und/oder beobachtung von synuclein- assoziierten krankheiten
NL1008619A1 (nl) Werkwijze voor het meten en aangeven van de mate waarin een persoon beperkt is in activiteiten van het dagelijks leven.
CY1108397T1 (el) Αντι-ccr4 αντισωμα και θραυσμα αυτου
DE60035643D1 (de) Verfahren und Vorrichtung zur Messung von Refraktionseigenschaften des menschlichen Auges
AT359623B (de) Verfahren zum differenzierten diagnostizieren pathologischer veraenderungen innerhalb menschlichen koerpergewebes, sowie vorrichtung zum durchfuehren des verfahrens
DE602004015389D1 (de) Vorrichtung, Verfahren und Computerprogramm zur Bestimmung des physischen Aktivitätsgrades eines Menschen
DE69132335D1 (de) Verfahren und Vorrichtung zum Erlangen von zerstörungsfreien Messungen an Objekten mit regelmässigen Formen
DD133409A5 (de) Verfahren fuer die vermahlung von getreide und vorrichtung zur durchfuehrung des verfahrens
IT7867398A0 (it) Dispositivo di autenticazione di elementi in foglio particolarmente banconote e metodo per la sua attuazione
DE60043294D1 (de) Verfahren und vorrichtung zur augenverfolgung
AT385826B (de) Reibring fuer kupplungen oder bremsen, verfahren und vorrichtung zum herstellen des reibringes
DE3861974D1 (de) Vorrichtung und verfahren zur messung des schwerpunktes eines flugzeuges.
DE68917383D1 (de) Verfahren und Vorrichtung zum schnellen Bestimmung des Schlamminhalts.
ATE401035T1 (de) Verfahren und vorrichtung zur messung des dynamischen verhaltens des auges
DE3861973D1 (de) Vorrichtung und verfahren zum messen des schwerpunktes eines flugzeuges.
ATE235922T1 (de) Verfahren zum nachweis oder zur überwachung der wirksamkeit der behandlung durch t-zellen vermittelter erkrankungen
DE3872718D1 (de) Verfahren zum massieren von fleischhaltigem oder fleischaehnlichem gut und vorrichtung zur durchfuehrung des verfahrens.
WO2003076871A3 (de) Anordnung und verfahren zum messen von geometrien von im wesentlichen zweidimensionalen objekten
DE3750876D1 (de) Verfahren und Vorrichtung zum kapazitiven Druckfühlen.
ATE360812T1 (de) Verfahren und vorrichtung zum nachweis sehr geringer partikelmengen
DE69016427D1 (de) Verfahren zum dokumentieren und messen in der zahnheilkunde sowie vorrichtung zur durchführung des verfahrens.
ATA2289A (de) Vorrichtung zur messung des blutdruckes am menschlichen oder tierischen koerper
DE3789302D1 (de) Verfahren und Vorrichtung zum Erkennen des Zeitpunkts des Eisprungs bei Frauen durch Messen der Viscoelastizität vom Speichel.
DE69407756D1 (de) Verfahren und vorrichtung zum kontinuierlichen messen des blutdrucks

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0847281

Country of ref document: EP